Ashton Thomas Securities LLC Has $1.92 Million Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Ashton Thomas Securities LLC increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 3,678 shares of the medical equipment provider’s stock after purchasing an additional 273 shares during the period. Ashton Thomas Securities LLC’s holdings in Intuitive Surgical were worth $1,920,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in ISRG. Howard Capital Management Group LLC lifted its stake in Intuitive Surgical by 4.5% in the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock worth $1,044,000 after acquiring an additional 92 shares in the last quarter. Principal Financial Group Inc. lifted its position in shares of Intuitive Surgical by 1.5% in the third quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock worth $295,938,000 after purchasing an additional 9,194 shares in the last quarter. Quest Partners LLC acquired a new stake in shares of Intuitive Surgical during the third quarter worth approximately $173,000. Great Valley Advisor Group Inc. grew its position in Intuitive Surgical by 2.7% during the third quarter. Great Valley Advisor Group Inc. now owns 2,543 shares of the medical equipment provider’s stock valued at $1,249,000 after purchasing an additional 66 shares in the last quarter. Finally, Algert Global LLC acquired a new position in Intuitive Surgical in the 3rd quarter valued at approximately $1,988,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Up 3.3 %

ISRG opened at $508.58 on Tuesday. The stock’s 50 day moving average price is $561.62 and its two-hundred day moving average price is $532.25. The firm has a market capitalization of $181.15 billion, a P/E ratio of 79.34, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00.

Insider Activity

In other news, CFO Jamie Samath sold 94 shares of the company’s stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the transaction, the chief financial officer now owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Robert Desantis sold 11,545 shares of the stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 33,754 shares of company stock valued at $17,691,621. 0.90% of the stock is owned by company insiders.

Analyst Ratings Changes

Several equities analysts have recently commented on ISRG shares. Leerink Partners boosted their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. BTIG Research upped their target price on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Wells Fargo & Company lifted their price target on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Robert W. Baird dropped their price objective on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a report on Tuesday, March 18th. Finally, Barclays lifted their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average price target of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.